Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Current Opinion in Neurology|August 11, 2020
Chronic axonal idiopathic polyneuropathy: is it really benignKristin Samuelsson, Rayomand PressFrontiers in Neurology|February 28, 2018
Microangiopathy-A Potential Contributing Factor to Idiopathic Polyneuropathy: A Mini ReviewKristin Samuelsson, Rayomand PressJournal of Clinical Neurology (Seoul, Korea)|May 16, 2014
Idiopathic small fiber neuropathy: phenotype, etiologies, and the search for fabry diseaseKristin Samuelsson, Konstantinos Kostulas, Magnus Vrethem, et al.Rapid Communications in Mass Spectrometry : RCM|April 25, 2014
The application of a new microfluidic device for the simultaneous identification and quantitation of midazolam metabolites obtained from a single micro-litre of chimeric mice bloodRichard Gallagher, Leonard Dillon, Aidan Grimsley, et al.Contact Dermatitis|December 24, 2014
Investigation of diethylthiourea and ethyl isothiocyanate as potent skin allergens in chloroprene rubberAhmad G Ramzy, Lina Hagvall, Mansoureh N Pei, et al.Anticancer Research|January 30, 2008
Quantitative structure-cytotoxicity relationship analysis of phenoxazine derivatives by semiempirical molecular-orbital methodMariko Ishihara, Masami Kawase, Gunnar Westman, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 19, 2022
Hereditary transthyretin amyloidosis in Sweden: Comparisons between a non-endemic and an endemic regionKristin Samuelsson, Ana Jovanovic, Karl Egervall, et al.Chemical Research in Toxicology|November 16, 2010
Diphenylthiourea, a common rubber chemical, is bioactivated to potent skin sensitizersKristin Samuelsson, Moa Andresen Bergström, Charlotte A Jonsson, et al.Biochemical Pharmacology|June 5, 2013
Drug-drug interactions and metabolism in cytochrome P450 2C knockout mice: application to troleandomycin and midazolamAidan Grimsley, Richard Gallagher, Michael Hutchison, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 12, 2022
Dying from ALS in Sweden: clinical status, setting, and symptomsStefan Sennfält, Ulf Kläppe, Sebastian Thams, et al.Pageof 5